发明名称 Use of carbocycline derivs. - esp. iloprost, cicaprost, eptaloprost, beraprost or ciprostene, for treatment of vitiligo
摘要 The use of carbocycline derivs. (I) and their base salts and cyclodextrin clathrates for the treatment of vitiligo is new. (I) is pref. iloprost, cicaprost, eptaloprost, beraprost or ciprostene. USE/ADVANTAGE - (I) are TNF-synthesis inhibitors and are pref. applied topically in conventional dosage forms contg. 20-40 mcg/g vehicle. Max. tolerated daily dose is 80-160 mcg. (I) are superior to monoclonal antibodies against TNF and have reduced side effects compared with other known treatments such as PUVA therapy. They are vascular protective, produce a long term hyperpigmentation when used topically and are also active when used prophylactically
申请公布号 DE4124693(A1) 申请公布日期 1993.01.28
申请号 DE19914124693 申请日期 1991.07.22
申请人 SCHERING AG BERLIN UND BERGKAMEN, 1000 BERLIN, DE 发明人 BLITTSTEIN-WILLINGER, EVELINE, DR., 1000 BERLIN, DE
分类号 A61K31/557 主分类号 A61K31/557
代理机构 代理人
主权项
地址